You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Interferon alpha-2

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Infection and Its Clinical Prognosis in Chronic

Recruiting
  • Chronic Hepatitis B
  • COVID-19 Infection
  • Beijing, Beijing, China
    Department of Hepatology Division 2, Beijing Ditan Hospital
Mar 28, 2023

Triple -Negative Breast Cancer, Estrogen Receptor Negative, HER2/Neu Negative Trial in Buffalo (procedure, drug, biological)

Active, not recruiting
  • Triple -Negative Breast Cancer
  • +4 more
  • Biopsy
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Aug 1, 2022

Viral Hepatitis B, Viral Hepatitis D, Cirrhosis, Liver Trial in Worldwide (REP 2139-Mg, Tenofovir Disoproxil Fumarate, Pegylated

Available
  • Viral Hepatitis B
  • +6 more
  • REP 2139-Mg
  • +2 more
  • Vienna, Austria
  • +12 more
Feb 1, 2023

Primary Myelofibrosis, Secondary Myelofibrosis Trial in Scottsdale (Laboratory Biomarker Analysis, Quality-of-Life Assessment,

Active, not recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 7, 2022

Sarcoma, Kaposi, HIV Trial in New York (Interferon alfa-2b, Zidovudine, Sargramostim)

Completed
  • Sarcoma, Kaposi
  • HIV Infections
  • Interferon alfa-2b
  • +2 more
  • New York, New York
    Mem Sloan - Kettering Cancer Ctr
Oct 26, 2021

Melanoma Trial in Houston (Temozolomide (TMZ), Pegylated Interferon Alpha-2b (PGI))

Completed
Has Results
  • Melanoma
  • Temozolomide (TMZ)
  • Pegylated Interferon Alpha-2b (PGI)
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 1, 2020

Sarcoma, Kaposi, HIV Trial in United States (Interferon alfa-2a, Zidovudine)

Completed
  • Sarcoma, Kaposi
  • HIV Infections
  • Miami, Florida
  • +8 more
Oct 26, 2021

HIV Trial in Puerto Rico, United States (Interferon alfa-2a, Zidovudine)

Completed
  • HIV Infections
  • Chicago, Illinois
  • +8 more
Oct 28, 2021

Polycythemia Vera Trial in Italy (AOP2014, Phlebotomies, ASA)

Active, not recruiting
  • Polycythemia Vera
  • San Giovanni Rotondo, (FG) Puglia, Italy
  • +22 more
Jan 10, 2023

Colorectal Cancer, Colorectal Carcinoma, Colorectal Tumors Trial in Pittsburgh (Chemokin Modulatory Regimen (5 MU/m2), Chemokin

Terminated
Has Results
  • Colorectal Cancer
  • +3 more
  • Chemokin Modulatory Regimen (5 MU/m2)
  • +2 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Aug 21, 2020

Melanoma Trial in Houston (Temozolomide, Velban, Cisplatin)

Terminated
Has Results
  • Melanoma
  • Houston, Texas
    U.T.M.D. Anderson Cancer Center
Sep 1, 2020

Zidovudine vs. Zidovudine Plus Alpha Interferon vs. Interferon

Active, not recruiting
  • HIV
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in

    Withdrawn
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +4 more
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Jun 3, 2021

    Polycythemia Vera Trial in Tianjin (Ruxolitinib, Pegylated interferon a-2b)

    Recruiting
    • Polycythemia Vera
    • Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    May 19, 2023

    Hepatitis B, Chronic Trial in Shanghai (hepalatide, Pegylated Interferon, TAF)

    Not yet recruiting
    • Hepatitis B, Chronic
    • Shanghai, Shanghai, China
      Shanghai Tong Ren Hospital
    Nov 12, 2021

    Hepatitis C, Chronic Trial in Taiwan (PEGASYS 180 µg Q1W, P1101 180 µg Q1W, 48 doses, P1101 270µg Q1W, 48 doses)

    Completed
    • Hepatitis C, Chronic
    • PEGASYS 180 µg Q1W
    • +3 more
    • Changhua, Taiwan
    • +12 more
    Oct 7, 2021

    Malignant Melanoma, Recurrent Melanoma Trial (Dacarbazine, Fotemustine, Interferon Alfa-2b)

    Completed
    Has Results
    • Malignant Melanoma
    • Recurrent Melanoma
    • (no location specified)
    Oct 18, 2020

    Breastcancer, Breast Tumor Trial in United States (SV-BR-1-GM, Cyclophosphamide, Interferon-alpha-2b)

    Completed
    Has Results
    • Breastcancer
    • Breast Neoplasm
    • SV-BR-1-GM
    • +2 more
    • Santa Rosa, California
    • +4 more
    Jan 27, 2021

    Cutaneous Squamous Cell Carcinoma, Squamous Cell Carcinoma, Advanced Squamous Cell Carcinoma Trial in Miami (Cemiplimab-Rwlc,

    Not yet recruiting
    • Cutaneous Squamous Cell Carcinoma
    • +2 more
    • Miami, Florida
      Miami Cancer Institute at Baptist Health, Inc.
    Feb 6, 2023

    Chronic Hepatitis B Trial in China (ABI-H0731, ETV, Peg-IFNa)

    Active, not recruiting
    • Chronic Hepatitis B
    • Beijing, Beijing, China
    • +8 more
    Mar 17, 2022

    Lymphoma Trial in Houston (Fludarabine, Novantrone, Decadron)

    Completed
    Has Results
    • Lymphoma
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Oct 22, 2020

    Hepatitis B Trial in Worldwide (GSK3228836, PegIFN, NA therapy)

    Active, not recruiting
    • Hepatitis B
    • Sacramento, California
    • +48 more
    Jan 19, 2023

    CoVid 19 Positive Trial in Los Angeles (Hydroxychloroquine, Azithromycin, Hydroxychloroquine, Doxycycline, Hydroxychloroquine,

    Completed
    • CoVid 19 Positive
    • Hydroxychloroquine, Azithromycin
    • +10 more
    • Los Angeles, California
      FHHI-OI-Camelot; QME
    Nov 10, 2020

    Polycythemia Vera Trial in London, Oxford (Ruxolitinib, Hydroxycarbamide, Interferon-Alpha)

    Recruiting
    • Polycythemia Vera
    • London, United Kingdom
    • +1 more
    Nov 29, 2021

    Chronic Hepatitis B Virus Infection Trial in Worldwide (PEG-IFNa, BRII-835)

    Not yet recruiting
    • Chronic Hepatitis B Virus Infection
    • Kingswood, New South Wales, Australia
    • +28 more
    Jul 21, 2023